Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, November 2000, p. 3087-3091, Vol. 44, No. 11
Division of Infectious Diseases, Department of Medicine,
Santa Clara Valley Medical Center,1 and
California Institute for Medical
Research,2 San Jose, California 95128;
Division of Infectious Diseases and Geographic Medicine,
Department of Medicine,3 and
Department of Pathology,4 Stanford
University, Stanford, California 94305; Veterans Affairs
Health Care System, Palo Alto, California
943045; Department of Medical
Microbiology and Immunology, University of California at Davis,
Davis, California 956166; and Kaweah
Delta District Hospital, Visalia, California
932917
Received 18 January 2000/Returned for modification 11 May
2000/Accepted 18 July 2000
A rabbit model of coccidioidal meningitis was used to compare the
therapeutic efficacies of terbinafine (TBF) and fluconazole (FCZ).
Hydrocortisone acetate-treated New Zealand White male rabbits were
infected intracisternally with either 2.2 × 104 or
6.4 × 104 Coccidioides immitis
arthroconidia. Oral treatment with polyethylene glycol 200 (PEG) twice
daily (n = 8), TBF twice daily (n = 9; 200 mg/kg of body weight/day), or FCZ once daily (n = 8; 80 mg/kg/day) began on day 5 and continued for 21 days. Mean
survival times were 20, 24, and 32 days for rabbits treated with PEG,
TBF, and FCZ, respectively. All of the FCZ-treated animals (100%;
P = 0.003), 56% of the TBF-treated animals
(P = 0.4), and 25% of the PEG-treated animals
survived the length of the study. Both FCZ and TBF were effective at
reducing the incidence of paresis. Only FCZ was effective at reducing
most neurological and systemic signs. FCZ treatments resulted in lower
cerebrospinal fluid (CSF) protein concentrations and leukocyte counts
and faster clearing of CSF fungal cultures compared with those for
PEG-treated controls, but TBF treatments had no significant effect on
these parameters. Neither drug affected CSF glucose levels. Mean serum
TBF levels by bioassay were within the range of 3.5 to 6.2 µg/ml at
1, 2, and 4 h postdosing and 0.35 to 7.0 µg/ml at 14 h
postdosing. No TBF was detected in CSF. Mean FCZ levels (24 to
25.5 h postdosing) by bioassay were 16.4 to 19.2 and 13.5 to 19.2 µg/ml in serum and CSF, respectively. The reduction in the numbers of
CFU in the spinal cord and brain was over 100-fold (P = 0.0005) in FCZ-treated animals and 2-fold (P
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Comparative Efficacies of Terbinafine and Fluconazole in
Treatment of Experimental Coccidioidal Meningitis in a Rabbit
Model

0.2)
in TBF-treated animals compared with those in PEG-treated animals.
Histopathologic severity (semiquantitative scoring system) was
significantly attenuated by FCZ treatment (P = 0.05)
and was slightly attenuated by TBF treatment compared with that for the controls. In conclusion, TBF appeared to have a slight effect on
survival, histology, and reduction of the numbers of CFU in tissue;
however, these effects were not significant. FCZ was effective at
controlling coccidioidal meningitis.
*
Corresponding author. Mailing address: Santa Clara
Valley Medical Center, 751 S. Bascom Ave., San Jose, CA 95128-2699. Phone: (408) 885-4313. Fax: (408) 885-4306. E-mail:
stevens{at}leland.stanford.edu.
Present address: P.O. Box 1143, Gunnison, UT 84634-1143.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |